Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000570274

Apexbio Technology LLC CEFPODOXIME-D3-1MG
SDP

Catalog No. 5000570274
Encompass_Preferred

Cefpodoxime-d3 (CAS No 2477791-28-7) is a deuterated version of the third-generation cephalosporin antibiotic cefpodoxime used primarily in biomedical research to study its pharmacokinetics and metabolic pathways Originating from modifications of the standard cefpodoxime molecule it retains similar antibacterial activity by inhibiting bacterial cell wall synthesis through binding to penicillin-binding proteins effectively disrupting cell wall biosynthesis Typically exhibiting in vitro activity in the nanomolar to low micromolar range it is employed in various experimental setups including cell models and animal studies to investigate its efficacy and safety profile This compound is also pertinent in drug screening scenarios where detailed metabolic and pharmacokinetic data are required Experimental concentrations typically depend on the specific research design allowing flexibility for various investigative frameworks

Catalog No. 50-005-70274 Supplier Apexbio Technology LLC Supplier No. SL10591
May include imposed supplier surcharges.
Add to Cart
Add to Cart

Cefpodoxime-d3 (CAS No 2477791-28-7) is a deuterated version of the third-generation cephalosporin antibiotic cefpodoxime used primarily in biomedical research to study its pharmacokinetics and metabolic pathways Originating from modifications of the standard cefpodoxime molecule it retains similar antibacterial activity by inhibiting bacterial cell wall synthesis through binding to penicillin-binding proteins effectively disrupting cell wall biosynthesis Typically exhibiting in vitro activity in the nanomolar to low micromolar range it is employed in various experimental setups including cell models and animal studies to investigate its efficacy and safety profile This compound is also pertinent in drug screening scenarios where detailed metabolic and pharmacokinetic data are required Experimental concentrations typically depend on the specific research design allowing flexibility for various investigative frameworks

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.